SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021230
Filing Date
2020-11-13
Accepted
2020-11-13 09:00:46
Documents
51
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 487325
2 ex31-1.htm EX-31.1 39309
3 ex32-1.htm EX-32.1 13753
  Complete submission text file 0001493152-20-021230.txt   2299689

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE vbio-20200930.xml EX-101.INS 318548
5 XBRL SCHEMA FILE vbio-20200930.xsd EX-101.SCH 35598
6 XBRL CALCULATION FILE vbio-20200930_cal.xml EX-101.CAL 38089
7 XBRL DEFINITION FILE vbio-20200930_def.xml EX-101.DEF 66187
8 XBRL LABEL FILE vbio-20200930_lab.xml EX-101.LAB 218901
9 XBRL PRESENTATION FILE vbio-20200930_pre.xml EX-101.PRE 150077
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53832 | Film No.: 201309316
SIC: 8731 Services-Commercial Physical & Biological Research